Carmot Therapeutics

Carmot Therapeutics ("Carmot") is a biotechnology company dedicated to the discovery and development of innovative medicines. Carmot applies a transformative and patented drug discovery approach, Chemotype Evolution, to overcome major limitations in existing discovery methods, providing Carmot a unique opportunity to tackle challenging disease targets and identify superior therapeutics. Carmot is applying Chemotype Evolution internally and in collaboration with industry partners such as Amgen and Genentech. Carmot has identified drug leads targeting class-B GPCRs, protein-protein interactions, and deubiquitinating enzymes and is advancing a portfolio of wholly-owned programs in metabolic disease and oncology.